PASCAL Precision Transcatheter Valve Repair System
Edwards Lifesciences, LLC · Decision date Sep 9, 2026
What did the FDA decide?
This 30-day notice for P220003/S033 reports a process change by Edwards Lifesciences, LLC: reducing the receiving inspection levels for the Implant Catheter Shaft. The supplement type is a 30-Day Notice, and the stated reason is a process change involving manufacturer, sterilizer, packager, or supplier.
The database decision is OK30. The source statement does not describe the previous or new inspection levels, the sampling plan, or the acceptance criteria. It also does not state whether the change affects device safety or performance. A supplement is not a new approval of the whole PASCAL Precision Transcatheter Valve Repair System.
FDA approval order statement
reducing the receiving inspection levels for the Implant Catheter Shaft
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 9, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P220003/S033
- Regulatory pathway
- PMA supplement
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NKM
- Decision code
- OK30
- Decision date
- Sep 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Mitral valve repair devices.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NKM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P220003. Subsequent supplements may change the device or its indications.
FDA decision timeline
P220003 · Original PMA
PASCAL Precision Transcatheter Valve Repair System
P220003/S033 received
Application receipt date recorded by FDA.
P220003/S033 · FDA decision
30-Day Notice
P220003/S028 · Related supplement
PASCAL Ace with Capture Clarity Valve Repair System MR Implant System
P220003/S029 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
P220003/S032 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
Timeline entries are records held by MedtechLedger for P220003. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P220003
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA approval | Sep 14, 2022 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 20, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P220003/S033
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records